J. Goldman & Co LP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2017$661,000
-93.4%
9,300
-95.3%
0.03%
-95.1%
Q4 2016$10,069,000
+332.1%
197,200
+289.7%
0.67%
+405.3%
Q3 2016$2,330,000
-64.1%
50,600
-76.5%
0.13%
-61.1%
Q2 2016$6,493,000
+98.6%
215,500
+111.3%
0.34%
+67.0%
Q1 2016$3,270,000102,0000.20%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders